Abdul-Ghani M and others, ‘Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?’ (2017) 40 Diabetes Care 813
Adamsson Eryd S and others, ‘Risk of Future Microvascular and Macrovascular Disease in People with Type 1 Diabetes of Very Long Duration: A National Study with 10-Year Follow-Up’ (2017) 34 Diabetic Medicine 411
Andersson DP and others, ‘Association between Treatment for Erectile Dysfunction and Death or Cardiovascular Outcomes after Myocardial Infarction’ [2017] Heart
‘Assessing the Relationship between Admission Glucose Levels, Subsequent Length of Hospital Stay, Readmission and Mortality.’ Prime <https://wwww.unboundmedicine.com/medline/citation/22586788/Assessing_the_relationship_between_admission_glucose_levels_subsequent_length_of_hospital_stay_readmission_and_mortality_>
Atkinson MA, Eisenbarth GS and Michels AW, ‘Type 1 Diabetes’ (2014) 383 The Lancet 69
Azmi S and others, ‘Small-Fibre Neuropathy in Men with Type 1 Diabetes and Erectile Dysfunction: A Cross-Sectional Study’ [2017] Diabetologia
Bangalore S and others, ‘Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials’ (2011) 123 Circulation 2799
Barzilay JI and others, ‘Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study’ (2012) 5 Circulation: Cardiovascular Quality and Outcomes 153
Bianchi C, Miccoli R and Del Prato S, ‘Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?’ (2013) 13 Current Diabetes Reports 403
——, ‘Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?’ (2013) 13 Current Diabetes Reports 403
Black JA and others, ‘Change in Cardiovascular Risk Factors Following Early Diagnosis of Type 2 Diabetes: A Cohort Analysis of a Cluster-Randomised Trial’ (2014) 64 British Journal of General Practice e208
Boulton AJ and others, ‘International Collaborative Research on Charcot’s Disease - 2009’ (2009) 373 The Lancet 105
Boussageon R and others, ‘Effect of Intensive Glucose Lowering Treatment on All Cause Mortality, Cardiovascular Death, and Microvascular Events in Type 2 Diabetes: Meta-Analysis of Randomised Controlled Trials’ (2011) 343 BMJ d4169
Braffett BH, Wessells H and Sarma AV, ‘Urogenital Autonomic Dysfunction in Diabetes’ (2016) 16 Current Diabetes Reports
Çakici N and others, ‘Systematic Review of Treatments for Diabetic Peripheral Neuropathy’ (2016) 33 Diabetic Medicine 1466
——, ‘Systematic Review of Treatments for Diabetic Peripheral Neuropathy’ (2016) 33 Diabetic Medicine 1466
‘Cardiovascular Outcome Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0140673614607947>
Cefalu WT and others, ‘Getting to the "Heart” of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory”’ (2016) 39 Diabetes Care 664
Chatterjee S, Khunti K and Davies MJ, ‘Type 2 Diabetes’ [2017] The Lancet
Cheung N, Mitchell P and Wong TY, ‘Diabetic Retinopathy’ (2010) 376 The Lancet 124
Chloe L. Edridge, ‘Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies’ (2015) 10 PLoS ONE <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465495/>
Clokie M and others, ‘New Horizons in the Understanding of the Causes and Management of Diabetic Foot Disease: Report from the 2017 Diabetes UK Annual Professional Conference Symposium’ (2017) 34 Diabetic Medicine 305
Dahlöf B and others, ‘Prevention of Cardiovascular Events with an Antihypertensive Regimen of Amlodipine Adding Perindopril as Required versus Atenolol Adding Bendroflumethiazide as Required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A Multicentre Randomised Controlled Trial’ (2005) 366 The Lancet 895
Dana Dabelea, ‘Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood’ 317 JAMA 825 <http://jamanetwork.com/journals/jama/fullarticle/2606400>
Denig P and others, ‘Effects of a Patient Oriented Decision Aid for Prioritising Treatment Goals in Diabetes: Pragmatic Randomised Controlled Trial’ (2014) 349 BMJ g5651
Dhatariya K and others, ‘NHS Diabetes Guideline for the Perioperative Management of the Adult Patient with Diabetes’ (2012) 29 Diabetic Medicine 420
Dhatariya KK and Vellanki P, ‘Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA)’ (2017) 17 Current Diabetes Reports
‘Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: A Collaborative Meta-Analysis of 102 Prospective Studies’ (2010) 375 The Lancet 2215
‘Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death’ (2011) 364 New England Journal of Medicine 829
‘Diabetes Mellitus Type 2: A Driving Force for Urological Complications - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1043276016000321>
‘——’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1043276016000321>
‘Diabetic Foot Problems: Prevention and Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng19>
Duckworth W and others, ‘Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes’ (2009) 360 New England Journal of Medicine 129
Dwamena F and others, ‘Interventions for Providers to Promote a Patient-Centred Approach in Clinical Consultations’, Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <http://doi.wiley.com/10.1002/14651858.CD003267.pub2>
‘Effect of Intensive Blood-Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34)’ (1998) 352 The Lancet 854
‘Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus’ (2010) 362 New England Journal of Medicine 1563
‘Effects of Different Blood Pressure–Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus’ (2005) 165 Archives of Internal Medicine
‘Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus’ (2010) 362 New England Journal of Medicine 1575
‘——’ (2010) 362 New England Journal of Medicine 1575
‘Effects of Intensive Glucose Lowering in Type 2 Diabetes’ (2008) 358 New England Journal of Medicine 2545
‘Effects of Reducing Blood Pressure on Renal Outcomes in Patients with Type 2 Diabetes: Focus on SGLT2 Inhibitors and EMPA-REG OUTCOME - ClinicalKey’ <https://www.clinicalkey.com/#!/content/journal/1-s2.0-S1262363617300022>
Ele Ferrannini, ‘Impact of Glucose-Lowering Drugs on Cardiovascular Disease in Type 2 Diabetes’ (2015) 36 European Heart Journal 2288 <http://eurheartj.oxfordjournals.org/content/36/34/2288>
Elliott WJ and Meyer PM, ‘Incident Diabetes in Clinical Trials of Antihypertensive Drugs: A Network Meta-Analysis’ (2007) 369 The Lancet 201
Ferrannini E and Cushman WC, ‘Diabetes and Hypertension: The Bad Companions’ (2012) 380 The Lancet 601
Filippatos T and others, ‘Pathophysiology of Diabetic Dyslipidaemia’ (2017) 15 Current Vascular Pharmacology 1
Fisher L, Gonzalez JS and Polonsky WH, ‘The Confusing Tale of Depression and Distress in Patients with Diabetes: A Call for Greater Clarity and Precision’ (2014) 31 Diabetic Medicine 764
Foresta C and others, ‘The Great Opportunity of the Andrological Patient: Cardiovascular and Metabolic Risk Assessment and Prevention’ [2017] Andrology
Fox CS and others, ‘Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association’ (2015) 38 Diabetes Care 1777
‘Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes’ (2017) 376 New England Journal of Medicine 1507
Gæde P and others, ‘Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes’ (2008) 358 New England Journal of Medicine 580
——, ‘Years of Life Gained by Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus and Microalbuminuria: 21 Years Follow-up on the Steno-2 Randomised Trial’ (2016) 59 Diabetologia 2298
Game F, ‘Classification of Diabetic Foot Ulcers’ (2016) 32 Diabetes/Metabolism Research and Reviews 186
Giorgino F, Home PD and Tuomilehto J, ‘Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?’ (2016) 39 Diabetes Care S187
Giovanni Corona, ‘Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors’ (2016) 11 PLoS ONE <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051725/>
Hayward RA and others, ‘Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes’ (2015) 372 New England Journal of Medicine 2197
——, ‘Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes’ (2015) 372 New England Journal of Medicine 2197
Holman RR and others, ‘10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes’ (2008) 359 New England Journal of Medicine 1577
——, ‘Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes’ (2017) 377 New England Journal of Medicine 1228
Holt RIG, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
Holt RIG, ‘Understanding of the Causes and Management of Diabetic Foot Disease’ (2017) 34 Diabetic Medicine 303
Holt RIG and others, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
—— (eds), Textbook of Diabetes (Fifth edition, Wiley Blackwell 2017) <http://ezproxy.lib.le.ac.uk/login?url=http://ebookcentral.proquest.com.ezproxy3.lib.le.ac.uk/lib/leicester/detail.action?docID=4769056>
Hotaling JM and others, ‘Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes’ (2016) 39 Diabetes Care 1587
——, ‘Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes’ (2016) 39 Diabetes Care 1587
‘Hypertension: Clinical Management of Primary Hypertension in Adults | NICE Guideline 127. August 2011’ <http://www.nice.org.uk/guidance/cg127>
Ian Blumer, MD, FRCPC1, 2, Maureen Clement, MD, CCFP3, , ‘Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges’ Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges <http://www.sciencedirect.com.ezproxy4.lib.le.ac.uk/science/article/pii/S0149291816307792>
‘Integration of Recent Evidence into Management of Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858717300335>
‘Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes’ (2008) 358 New England Journal of Medicine 2560
‘Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes’ (2005) 353 New England Journal of Medicine 2643
‘Intensive Systolic Blood Pressure Control and Incident Chronic Kidney Disease in People with and without Diabetes Mellitus: Secondary Analyses of Two Randomised Controlled Trials- ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300998>
International Textbook of Diabetes Mellitus (4th edn, John Wiley & Sons, Incorporated 2015) <http://ebookcentral.proquest.com.ezproxy3.lib.le.ac.uk/lib/leicester/detail.action?docID=1895437>
Jhamb S, Vangaveti VN and Malabu UH, ‘Genetic and Molecular Basis of Diabetic Foot Ulcers: Clinical Review’ (2016) 25 Journal of Tissue Viability 229
Jin D and others, ‘Effect of Transcutaneous Electrical Nerve Stimulation on Symptomatic Diabetic Peripheral Neuropathy: A Meta-Analysis of Randomized Controlled Trials’ (2010) 89 Diabetes Research and Clinical Practice 10
Johal S and others, ‘Pre-Existing Diabetes Is a Risk Factor for Increased Rates of Cellular Rejection after Kidney Transplantation: An Observational Cohort Study’ [2017] Diabetic Medicine
Kaul S, ‘Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials’ (2017) 40 Diabetes Care 821
Khunti K and others, ‘Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More than 80,000 People’ (2013) 36 Diabetes Care 3411
Khunti K and others, ‘Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study’ (2015) 38 Diabetes Care 316
——, ‘Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study’ (2015) 38 Diabetes Care 316
Koye DN and others, ‘Incidence of Chronic Kidney Disease among People with Diabetes: A Systematic Review of Observational Studies’ [2017] Diabetic Medicine
Kunutsor SK, Seidu S and Khunti K, ‘Aspirin for Primary Prevention of Cardiovascular and All-Cause Mortality Events in Diabetes: Updated Meta-Analysis of Randomized Controlled Trials’ (2017) 34 Diabetic Medicine 316
Liew G, Mitchell P and Wong TY, ‘Systemic Management of Diabetic Retinopathy’ (2009) 338 BMJ b441
Lindholm LH and others, ‘Cardiovascular Morbidity and Mortality in Patients with Diabetes in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): A Randomised Trial against Atenolol’ (2002) 359 The Lancet 1004
‘Lipid-Lowering Efficacy of the PCSK9 Inhibitor Evolocumab (AMG 145) in Patients with Type 2 Diabetes: A Meta-Analysis of Individual Patient Data - ClinicalKey’ <https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858716000036>
‘Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes’ (2011) 364 New England Journal of Medicine 818
‘Macrovascular Disease and Risk Factors in Youth with Type 1 Diabetes: Time to Be More Attentive to Treatment?- ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354>
‘——’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354>
‘——’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300354>
Malavige LS and others, ‘The Association between Physical Activity and Sexual Dysfunction in Patients with Diabetes Mellitus of European and South Asian Origin: The Oxford Sexual Dysfunction Study’ (2015) 20 European Journal of Medical Research
Marso SP and others, ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’ (2016) 375 New England Journal of Medicine 311
Matheus AS de M and others, ‘Impact of Diabetes on Cardiovascular Disease: An Update’ (2013) 2013 International Journal of Hypertension 1
Mayer-Davis EJ and others, ‘Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012’ (2017) 376 New England Journal of Medicine 1419
Melanie Davies, ‘The Treatment of Type 2 Diabetes in the Presence of Renal Impairment: What We Should Know about Newer Therapies’ (2016) 8 Clinical Pharmacology : Advances and Applications <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922775/>
Micha R and others, ‘Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States’ (2017) 317 JAMA
‘Microvascular Complications and Foot Care’ (2017) 40 Diabetes Care S88
Miller ME and others, ‘The Effects of Baseline Characteristics, Glycaemia Treatment Approach, and Glycated Haemoglobin Concentration on the Risk of Severe Hypoglycaemia: Post Hoc Epidemiological Analysis of the ACCORD Study’ (2010) 340 BMJ b5444
‘Minimizing Hypoglycemia in Diabetes: Table 1’ (2015) 38 Diabetes Care 1583
Moreton RBR and others, ‘Factors Determining Uptake of Diabetic Retinopathy Screening in Oxfordshire’ (2017) 34 Diabetic Medicine 993
‘Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes’ (2017) 377 New England Journal of Medicine 300
Navaneethan SD and others, ‘Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD’ [2017] American Journal of Kidney Diseases
Nicolucci A and Standl E, ‘Antiplatelet Therapy for Every Diabetic Person?’ (2011) 34 Diabetes Care S150
‘Older Antidiabetic Drugs | The British Journal of Cardiology’ <https://bjcardio.co.uk/2018/03/older-antidiabetic-drugs/>
Omland T and others, ‘Relation of Erectile Dysfunction to Subclinical Myocardial Injury’ (2016) 118 The American Journal of Cardiology 1821
Orchard TJ and others, ‘Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-Term Mortality’ (2015) 313 JAMA
P Naidoo, ‘Lower Limb Complications of Diabetes Mellitus: A Comprehensive Review with Clinicopathological Insights from a Dedicated High-Risk Diabetic Foot Multidisciplinary Team’ (2015) 88 The British Journal of Radiology <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743571/>
Paul SK and others, ‘Delay in Treatment Intensification Increases the Risks of Cardiovascular Events in Patients with Type 2 Diabetes’ (2015) 14 Cardiovascular Diabetology
‘Personalised Blood Pressure Ranges in Type 2 Diabetes?- ClinicalKey’ <https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2213858718300020>
‘——’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858718300020>
‘Personalised Treatment Targets in Type 2 Diabetes Patients: The Dutch Approach - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S1751991816300626>
Pickering RJ and others, ‘Recent Novel Approaches to Limit Oxidative Stress and Inflammation in Diabetic Complications’ (2018) 7 Clinical & Translational Immunology
Piepoli MF and others, ‘2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice’ (2016) 252 Atherosclerosis 207
‘Proceedings of the 5th International DAWN Summit 2014: Acting Together to Make Person-Centred Diabetes Care a Reality - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0168822715001862>
Rawshani A and others, ‘Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes’ (2017) 376 New England Journal of Medicine 1407
——, ‘Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes’ (2017) 376 New England Journal of Medicine 1407
Ray KK and others, ‘Effect of Intensive Control of Glucose on Cardiovascular Outcomes and Death in Patients with Diabetes Mellitus: A Meta-Analysis of Randomised Controlled Trials’ (2009) 373 The Lancet 1765
Richard W. Nesto, ‘LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?’ (2008) 26 Clinical Diabetes <http://go.galegroup.com/ps/i.do?id=GALE|A174972167&v=2.1&u=leicester&it=r&p=EAIM&sw=w&asid=07d8e79bb8f42665bb52cc5732948c88>
Ritholz MD, MacNeil T and Weinger K, ‘Difficult Conversations: Adults with Diabetes and the Discussion of Microvascular Complications’ [2017] Diabetic Medicine
——, ‘Difficult Conversations: Adults with Diabetes and the Discussion of Microvascular Complications’ (2017) 34 Diabetic Medicine 1447
Romero-Aroca P and others, ‘Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-up Study’ [2017] British Journal of Ophthalmology
——, ‘Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-up Study’ [2017] British Journal of Ophthalmology
——, ‘Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-up Study’ [2017] British Journal of Ophthalmology
Rosenberg JB and Tsui I, ‘Screening for Diabetic Retinopathy’ (2017) 376 New England Journal of Medicine 1587
Saha SA and Arora RR, ‘Fibrates in the Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus – A Pooled Meta-Analysis of Randomized Placebo-Controlled Clinical Trials’ (2010) 141 International Journal of Cardiology 157
Santi D and others, ‘Six Months of Daily Treatment with Vardenafil Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 Diabetes and Erectile Dysfunction: A Randomized, Double-Blind, Prospective Trial’ (2016) 174 European Journal of Endocrinology 513
Schrier RW, Estacio RO and Jeffers B, ‘Appropriate Blood Pressure Control in NIDDM (ABCD) Trial’ (1996) 39 Diabetologia 1646
Scott AR, ‘Management of Hyperosmolar Hyperglycaemic State in Adults with Diabetes’ (2015) 32 Diabetic Medicine 714
Seidu S and others, ‘Effects of Glucose-Lowering and Multifactorial Interventions on Cardiovascular and Mortality Outcomes: A Meta-Analysis of Randomized Control Trials’ (2016) 33 Diabetic Medicine 280
Soliman EZ and others, ‘Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study’ (2017) 40 Diabetes Care 793
Solomon SD and others, ‘Diabetic Retinopathy: A Position Statement by the American Diabetes Association’ (2017) 40 Diabetes Care 412
——, ‘Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418’ [2017] Diabetes Care
——, ‘Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418’ [2017] Diabetes Care
——, ‘Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418’ (2017) 40 Diabetes Care 809.3
Sultan A and others, ‘Evolution of Silent Myocardial Ischaemia Prevalence and Cardiovascular Disease Risk Factor Management in Type 2 Diabetes over a 10-Year Period: An Observational Study’ [2017] Diabetic Medicine
——, ‘Evolution of Silent Myocardial Ischaemia Prevalence and Cardiovascular Disease Risk Factor Management in Type 2 Diabetes over a 10-Year Period: An Observational Study’ [2017] Diabetic Medicine
‘The Changing Face of Diabetes Complications - ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858716300109>
‘The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus’ (1993) 329 New England Journal of Medicine 977
‘The Evolution of Diabetic Ketoacidosis: An Update of Its Etiology, Pathogenesis and Management - ClinicalKey’ <https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0026049515003728>
‘The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management - NHS Health Check’ <http://www.healthcheck.nhs.uk/news/the_handbook_for_vascular_risk_assessment_risk_reduction_and_risk_management/>
Turnbull FM and others, ‘Intensive Glucose Control and Macrovascular Outcomes in Type 2 Diabetes’ (2009) 52 Diabetologia 2288
——, ‘Intensive Glucose Control and Macrovascular Outcomes in Type 2 Diabetes’ (2009) 52 Diabetologia 2288
‘Type 1 Diabetes in Adults: Diagnosis and Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng17>
‘Type 2 Diabetes in Adults: Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng28>
UK Prospective Diabetes Study Group, ‘Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38’ (1998) 317 BMJ : British Medical Journal <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC28659/>
Umpierrez G and Korytkowski M, ‘Diabetic Emergencies — Ketoacidosis, Hyperglycaemic Hyperosmolar State and Hypoglycaemia’ (2016) 12 Nature Reviews Endocrinology 222
——, ‘Diabetic Emergencies — Ketoacidosis, Hyperglycaemic Hyperosmolar State and Hypoglycaemia’ (2016) 12 Nature Reviews Endocrinology 222
Valencia WM and Florez H, ‘How to Prevent the Microvascular Complications of Type 2 Diabetes beyond Glucose Control’ [2017] BMJ
Wannamethee SG and others, ‘Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men: Influence of Age at Onset, Diabetes Duration and Established and Novel Rosk Factors’ (2011) 171 Archives of Internal Medicine
Webb DR and others, ‘Cardiovascular Risk Factors and Incident Albuminuria in Screen-Detected Type 2 Diabetes’ [2016] Diabetes/Metabolism Research and Reviews
Weber MA and others, ‘Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes’ (2010) 56 Journal of the American College of Cardiology 77
Whelton PK, ‘Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia’ (2005) 165 Archives of Internal Medicine
White J and others, ‘Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes’ (2016) 1 JAMA Cardiology
Wong MG and others, ‘Long-Term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON’ (2016) 39 Diabetes Care 694
——, ‘Long-Term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON’ (2016) 39 Diabetes Care 694
Yavuz M and others, ‘Plantar Shear Stress in Individuals With a History of Diabetic Foot Ulcer: An Emerging Predictive Marker for Foot Ulceration’ (2017) 40 Diabetes Care e14
Yudkin JS, Richter B and Gale EA, ‘Intensified Glucose Control in Type 2 Diabetes—Whose Agenda?’ (2011) 377 The Lancet 1220
Zaccardi F and others, ‘Predicting Hospital Stay, Mortality and Readmission in People Admitted for Hypoglycaemia: Prognostic Models Derivation and Validation’ [2017] Diabetologia
——, ‘Risk Factors and Outcome Differences in Hypoglycaemia-Related Hospital Admissions: A Case-Control Study in England’ [2017] Diabetes, Obesity and Metabolism
Zhang C-Y and others, ‘Effects of Intensive Glucose Control on Incidence of Cardiovascular Events in Patients with Type 2 Diabetes: A Meta-Analysis’ (2010) 42 Annals of Medicine 305
Zinman B and others, ‘Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes’ (2015) 373 New England Journal of Medicine 2117
Zoungas S and others, ‘Effects of Intensive Glucose Control on Microvascular Outcomes in Patients with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomised Controlled Trials’ (2017) 5 The Lancet Diabetes & Endocrinology 431
